Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Liver Transplant CGM

NCT: NCT07216508 · ENROLLING_BY_INVITATION

NCT IDNCT07216508

StatusENROLLING_BY_INVITATION

Start Date2025-10-13

Completion2027-12-30

SponsorIcahn School of Medicine at Mount Sinai (OTHER)

First posted2025-10-14

Last updated2026-08-24

Brief Summary

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑